NCT05796037Not yet recruiting
An Observational Study of Patients Living With Chronic Neurological Diseases
Source: ClinicalTrials.gov · Last updated 20 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
TARGET-NEURO is an observational research study to conduct a comprehensive review of outcomes for patients living with chronic neurological diseases: Alzheimer's disease and related dementia (ADRD), mild cognitive impairment (MCI), Parkinson's disease (PD), and multiple sclerosis (MS).
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1500000 (estimated)
- First submitted
- 9 Mar 2023
- Start date
- 31 Mar 2025
- Primary completion date
- 31 Dec 2038
- Lead sponsor
- Target PharmaSolutions, Inc.
- NCT number
- NCT05796037
What you commit to
- Study type: Observational
- Planned participants: 1500000
- From 31 Mar 2025 to the primary completion date, 31 Dec 2038
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Failure to complete PROs within 24 weeks of initial invitation
Age
- No EHR interface encounter \> 3 years
- Engaged Cohort
- Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort
- Age Cohort
- No EHR interface encounter \> 3 years
Other
- Death
- Manual removal (sponsor or site request)
- Patient expressed desire to withdraw consent to complete PROs
- Care partner expressed desire to withdraw consent to complete PROs
- Greater than 24 months lapse of survey completion after baseline surveys completed
- Death
- Manual removal (sponsor or site request)
Who the study is looking for
- •Adult patients at the time of enrollment with a diagnosis of ADRD, MCI, PD, or MS by select ICD-10 codes in the EHR interface
- Adult patients diagnosed and managed for these conditions invited to participate
- Ability to provide written informed consent (or have a legally authorized representative to provide informed consent)
- Care partners may be invited to participate in surveys and will provide informed consent.
- •Adult patients aged 60 and older at time of enrollment
Criteria the registry did not label
- Disease Cohort
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.